178 related articles for article (PubMed ID: 22036018)
21. Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.
Sangha S; Yao M; Wolfe MM
Postgrad Med J; 2005 Apr; 81(954):223-7. PubMed ID: 15811884
[TBL] [Abstract][Full Text] [Related]
22. Chemoprevention in hereditary colorectal cancer syndromes.
Hawk E; Lubet R; Limburg P
Cancer; 1999 Dec; 86(11 Suppl):2551-63. PubMed ID: 10630181
[TBL] [Abstract][Full Text] [Related]
23. [Aspirin for Chemoprevention of Colorectal Adenoma and Cancer].
Ishikawa H
Gan To Kagaku Ryoho; 2021 Dec; 48(12):1425-1428. PubMed ID: 34911904
[TBL] [Abstract][Full Text] [Related]
24. Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Mathers JC; Movahedi M; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans G; Maher ER; Bertario L; Bisgaard ML; Dunlop M; Ho JW; Hodgson S; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen H; Gerdes AM; Barker G; Crawford G; Elliott F; Pylvanainen K; Wijnen J; Fodde R; Lynch H; Bishop DT; Burn J;
Lancet Oncol; 2012 Dec; 13(12):1242-9. PubMed ID: 23140761
[TBL] [Abstract][Full Text] [Related]
25. Are aspirin and other non-steroidal anti-inflammatory drugs effective in the prevention and treatment of colorectal cancer?
Elder DJ; Paraskeva C
Lancet; 1996 Aug; 348(9025):485. PubMed ID: 8709821
[No Abstract] [Full Text] [Related]
26. Aspirin in the chemoprevention of colorectal neoplasia: an overview.
Chan AT; Arber N; Burn J; Chia WK; Elwood P; Hull MA; Logan RF; Rothwell PM; Schrör K; Baron JA
Cancer Prev Res (Phila); 2012 Feb; 5(2):164-78. PubMed ID: 22084361
[TBL] [Abstract][Full Text] [Related]
27. Hereditary nonpolyposis colorectal cancer: preventive management.
Annie Yu HJ; Lin KM; Ota DM; Lynch HT
Cancer Treat Rev; 2003 Dec; 29(6):461-70. PubMed ID: 14585257
[TBL] [Abstract][Full Text] [Related]
28. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
Topping DL; Bird AR; Young GP
N Engl J Med; 2009 Apr; 360(14):1462; author reply 1462-3. PubMed ID: 19348022
[No Abstract] [Full Text] [Related]
29. GPs' willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a factorial randomised trial investigating factors influencing decisions.
Lloyd KE; Hall LH; Ziegler L; Foy R; Borthwick GM; MacKenzie M; Taylor DG; Smith SG;
Br J Gen Pract; 2023 Apr; 73(729):e302-e309. PubMed ID: 36997217
[TBL] [Abstract][Full Text] [Related]
30. Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer-like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression.
Wood NJ; Quinton NA; Burdall S; Sheridan E; Duffy SR
Int J Gynecol Cancer; 2007; 17(2):447-54. PubMed ID: 17316360
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase as a target for colorectal cancer chemoprevention.
Moreira L; Castells A
Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
[TBL] [Abstract][Full Text] [Related]
32. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
Burn J; Bishop DT; Mecklin JP; Macrae F; Möslein G; Olschwang S; Bisgaard ML; Ramesar R; Eccles D; Maher ER; Bertario L; Jarvinen HJ; Lindblom A; Evans DG; Lubinski J; Morrison PJ; Ho JW; Vasen HF; Side L; Thomas HJ; Scott RJ; Dunlop M; Barker G; Elliott F; Jass JR; Fodde R; Lynch HT; Mathers JC;
N Engl J Med; 2008 Dec; 359(24):2567-78. PubMed ID: 19073976
[TBL] [Abstract][Full Text] [Related]
33. The CAPP II trial of aspirin in Lynch syndrome/HNPCC: is it time for everyone to be treated?
Lynch PM
Fam Cancer; 2021 Jan; 20(1):9-11. PubMed ID: 33420651
[No Abstract] [Full Text] [Related]
34. Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial.
Soualy A; Deutsch D; Benallaoua M; Ait-Omar A; Mary F; Helfen S; Boubaya M; Levy V; Benamouzig R;
Trials; 2020 Sep; 21(1):764. PubMed ID: 32887653
[TBL] [Abstract][Full Text] [Related]
35. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.
Syngal S; Weeks JC; Schrag D; Garber JE; Kuntz KM
Ann Intern Med; 1998 Nov; 129(10):787-96. PubMed ID: 9841584
[TBL] [Abstract][Full Text] [Related]
36. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
Yang F; Jin C; Fu D
N Engl J Med; 2009 Apr; 360(14):1461-2; author reply 1462-3. PubMed ID: 19339729
[No Abstract] [Full Text] [Related]
37. [Aspirin in the primary prevention of colorectal cancer].
Fernández Calderón M; Betés Ibáñez MT
An Sist Sanit Navar; 2012; 35(2):261-7. PubMed ID: 22948427
[TBL] [Abstract][Full Text] [Related]
38. Aspirin and the prevention of colorectal cancer.
Imperiale TF
N Engl J Med; 2003 Mar; 348(10):879-80. PubMed ID: 12621130
[No Abstract] [Full Text] [Related]
39. Aspirin for the prevention of colorectal cancer.
Garcia-Albeniz X; Chan AT
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):461-72. PubMed ID: 22122763
[TBL] [Abstract][Full Text] [Related]
40. Aspirin and nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: weighing the evidence.
Stürmer T; Buring JE; Glynn RJ
Ann Intern Med; 2007 Nov; 147(9):674; author reply 674-5. PubMed ID: 17975195
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
